TreeWAS – Variant ID: rs7867456

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N18.0 End-stage renal disease	0.446	0.554	0.000
N18 Chronic renal failure	0.423	0.577	0.000
N18.9 Chronic renal failure, unspecified	0.389	0.611	0.000
N18.3 Chronic kidney disease, stage 3	0.372	0.628	0.000
N18.1 Chronic kidney disease, stage 1	0.339	0.661	0.000
N18.8 Other chronic renal failure	0.325	0.675	0.000
N17-N19 Renal failure	0.315	0.685	0.000
N17 Acute renal failure	0.293	0.707	0.000
N17.0 Acute renal failure with tubular necrosis	0.280	0.720	0.000
N18.2 Chronic kidney disease, stage 2	0.279	0.721	0.000
N18.5 Chronic kidney disease, stage 5	0.262	0.738	0.000
N18.4 Chronic kidney disease, stage 4	0.259	0.741	0.000
N17.8 Other acute renal failure	0.230	0.770	0.000
N19 Unspecified renal failure	0.229	0.771	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.226	0.774	0.000
N17.2 Acute renal failure with medullary necrosis	0.210	0.790	0.000
N17.9 Acute renal failure, unspecified	0.135	0.865	0.000
D86.0 Sarcoidosis of lung	0.000	0.922	0.078
D86 Sarcoidosis	0.000	0.927	0.073
D86.9 Sarcoidosis, unspecified	0.000	0.927	0.073
D86.8 Sarcoidosis of other and combined sites	0.000	0.935	0.065
D86.3 Sarcoidosis of skin	0.000	0.950	0.050
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.952	0.047
D86.1 Sarcoidosis of lymph nodes	0.000	0.961	0.038
D80-D89 Certain disorders involving the immune mechanism	0.000	0.972	0.028
D82 Immunodeficiency associated with other major defects	0.000	0.978	0.022
D84 Other immunodeficiencies	0.000	0.979	0.021
N89.8 Other specified noninflammatory disorders of vagina	0.021	0.979	0.000
D81 Combined immunodeficiencies	0.000	0.979	0.021
D80 Immunodeficiency with predominantly antibody defects	0.000	0.979	0.021
D83 Common variable immunodeficiency	0.000	0.980	0.020
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.982	0.018
D82.1 Di George's syndrome	0.000	0.982	0.018
D84.9 Immunodeficiency, unspecified	0.000	0.983	0.017
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.983	0.017
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.984	0.016
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.984	0.016
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.984	0.016
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.984	0.016
D82.2 Immunodeficiency with short-limbed stature	0.000	0.984	0.016
D82.0 Wiskott-Aldrich syndrome	0.000	0.984	0.016
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.984	0.015
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.984	0.015
I49.8 Other specified cardiac arrhythmias	0.000	0.985	0.015
D84.1 Defects in the complement system	0.000	0.985	0.015
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.985	0.015
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.985	0.015
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.985	0.015
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.985	0.015
D81.9 Combined immunodeficiency, unspecified	0.000	0.985	0.015
D81.8 Other combined immunodeficiencies	0.000	0.985	0.015
D81.7 Major histocompatibility complex class II deficiency	0.000	0.985	0.015
D81.6 Major histocompatibility complex class I deficiency	0.000	0.985	0.015
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.985	0.015
D81.4 Nezelof's syndrome	0.000	0.985	0.015
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.985	0.015
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.985	0.015
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.985	0.015
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.985	0.015
D84.8 Other specified immunodeficiencies	0.000	0.985	0.015
D83.8 Other common variable immunodeficiencies	0.000	0.985	0.015
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.985	0.015
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.985	0.015
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.985	0.015
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.985	0.015
D83.9 Common variable immunodeficiency, unspecified	0.000	0.985	0.014
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.986	0.013
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.987	0.013
D89.1 Cryoglobulinaemia	0.000	0.987	0.013
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.988	0.012
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.989	0.011
D89.3 Immune reconstitution syndrome	0.000	0.989	0.011
Y40 Systemic antibiotics	0.000	0.990	0.010
Y40.0 Penicillins	0.000	0.990	0.010
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.991	0.009
Y40.9 Systemic antibiotic, unspecified	0.000	0.991	0.009
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.991	0.009
Y40.6 Rifamycins	0.000	0.991	0.009
R30.0 Dysuria	0.000	0.991	0.009
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.992	0.008
Y40.3 Macrolides	0.000	0.992	0.008
Y40.5 Aminoglycosides	0.000	0.992	0.008
Y40.7 Antifungal antibiotics, systemically used	0.000	0.992	0.008
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.000	0.992	0.008
Y40.4 Tetracyclines	0.000	0.992	0.008
Y40.8 Other systemic antibiotics	0.000	0.992	0.008
Z35.0 Supervision of pregnancy with history of infertility	0.008	0.992	0.000
Y40.2 Chloramphenicol group	0.000	0.992	0.007
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.993	0.007
Y52 Agents primarily affecting the cardiovascular system	0.000	0.993	0.007
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.994	0.006
Y41.5 Antiviral drugs	0.000	0.994	0.006
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.994	0.006
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.994	0.006
Y57 Other and unspecified drugs and medicaments	0.000	0.994	0.006
G71.0 Muscular dystrophy	0.006	0.994	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.994	0.006
Y57.9 Drug or medicament, unspecified	0.000	0.994	0.006
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.994	0.006
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.994	0.006
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.994	0.006
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.994	0.006
Y84.6 Urinary catheterisation	0.006	0.994	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.995	0.005
G71 Primary disorders of muscles	0.005	0.995	0.000
Y41.0 Sulphonamides	0.000	0.995	0.005
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
Y52.1 Calcium-channel blockers	0.000	0.995	0.005
G71.1 Myotonic disorders	0.005	0.995	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.005	0.995	0.000
Y57.5 X-ray contrast media	0.000	0.995	0.005
Y48 Anaesthetics and therapeutic gases	0.000	0.995	0.005
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.995	0.005
Y41.1 Antimycobacterial drugs	0.000	0.995	0.005
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.995	0.005
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.995	0.005
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.995	0.005
Y59 Other and unspecified vaccines and biological substances	0.000	0.995	0.005
A87.9 Viral meningitis, unspecified	0.005	0.995	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.995	0.005
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.995	0.005
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.995	0.005
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.995	0.005
Y41.4 Anthelminthics	0.000	0.995	0.005
Y41.3 Other antiprotozoal drugs	0.000	0.995	0.005
Y58 Bacterial vaccines	0.000	0.995	0.005
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.995	0.005
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.995	0.005
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.995	0.005
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.995	0.005
Y57.8 Other drugs and medicaments	0.000	0.995	0.005
Y52.7 Peripheral vasodilators	0.000	0.995	0.004
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.995	0.005
G72 Other myopathies	0.005	0.995	0.000
G72.9 Myopathy, unspecified	0.005	0.995	0.000
Y57.7 Vitamins, not elsewhere classified	0.000	0.995	0.004
Y57.4 Pharmaceutical excipients	0.000	0.995	0.004
Y57.3 Alcohol deterrents	0.000	0.995	0.004
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.004
Y57.1 Lipotropic drugs	0.000	0.995	0.004
Y57.0 Appetite depressants [anorectics]	0.000	0.995	0.004
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.995	0.004
Y46.2 Hydantoin derivatives	0.000	0.995	0.004
Y54.4 Loop [high-ceiling] diuretics	0.000	0.996	0.004
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
D51 Vitamin B12 deficiency anaemia	0.000	0.996	0.004
Y48.3 Local anaesthetics	0.000	0.996	0.004
G70-G73 Diseases of myoneural junction and muscle	0.004	0.996	0.000
Y59.0 Viral vaccines	0.000	0.996	0.004
Y46.4 Iminostilbenes	0.000	0.996	0.004
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
Y47.1 Benzodiazepines	0.000	0.996	0.004
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
G71.9 Primary disorder of muscle, unspecified	0.004	0.996	0.000
G71.8 Other primary disorders of muscles	0.004	0.996	0.000
G71.2 Congenital myopathies	0.004	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.000	0.996	0.004
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
R74.8 Abnormal levels of other serum enzymes	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
Y55.5 Anticommon cold drugs	0.000	0.996	0.004
Y55.3 Antitussives	0.000	0.996	0.004
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
Y55.0 Oxytocic drugs	0.000	0.996	0.004
Y48.4 Anaesthetic, unspecified	0.000	0.996	0.004
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.996	0.004
Y46.5 Valproic acid	0.000	0.996	0.004
M24.07 Loose body in joint (Ankle and foot)	0.000	0.996	0.004
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.996	0.004
G71.3 Mitochondrial myopathy, not elsewhere classified	0.004	0.996	0.000
Y48.5 Therapeutic gases	0.000	0.996	0.004
Y48.1 Parenteral anaesthetics	0.000	0.996	0.004
Y48.0 Inhaled anaesthetics	0.000	0.996	0.004
Y46.8 Antispasticity drugs	0.000	0.996	0.004
Y46.3 Deoxybarbiturates	0.000	0.996	0.004
Y46.1 Oxazolidinediones	0.000	0.996	0.004
Y46.0 Succinimides	0.000	0.996	0.004
D04.7 Skin of lower limb, including hip	0.004	0.996	0.000
G72.0 Drug-induced myopathy	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.996	0.004
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.996	0.004
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.996	0.004
Y47.4 Bromine compounds	0.000	0.996	0.004
Y47.3 Paraldehyde	0.000	0.996	0.004
Y47.2 Chloral derivatives	0.000	0.996	0.004
Y47.0 Barbiturates, not elsewhere classified	0.000	0.996	0.004
Y55.4 Expectorants	0.000	0.996	0.004
Y48.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
Y59.9 Vaccine or biological substance, unspecified	0.000	0.996	0.004
Y59.8 Other specified vaccines and biological substances	0.000	0.996	0.004
Y59.2 Protozoal vaccines	0.000	0.996	0.004
Y59.1 Rickettsial vaccines	0.000	0.996	0.004
D04.5 Skin of trunk	0.004	0.996	0.000
G72.8 Other specified myopathies	0.004	0.996	0.000
Y58.0 BCG vaccine	0.000	0.996	0.004
Y54.7 Agents affecting calcification	0.000	0.996	0.004
M79.79 Fibromyalgia (Site unspecified)	0.000	0.996	0.004
Y54.9 Mineral salts, not elsewhere classified	0.000	0.996	0.004
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.996	0.004
Y58.9 Other and unspecified bacterial vaccines	0.000	0.996	0.004
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.996	0.004
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.996	0.004
Y58.5 Diphtheria vaccine	0.000	0.996	0.004
Y58.4 Tetanus vaccine	0.000	0.996	0.004
Y58.3 Plague vaccine	0.000	0.996	0.004
Y58.2 Cholera vaccine	0.000	0.996	0.004
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.996	0.004
Y59.3 Immunoglobulin	0.000	0.996	0.004
G70 Myasthenia gravis and other myoneural disorders	0.004	0.996	0.000
I61 Intracerebral haemorrhage	0.000	0.996	0.004
D51.3 Other dietary vitamin B12 deficiency anaemia	0.000	0.996	0.004
Y46.7 Anti-Parkinsonism drugs	0.000	0.996	0.003
G72.1 Alcoholic myopathy	0.004	0.996	0.000
Y53.4 Other laxatives	0.000	0.996	0.004
D41.4 Bladder	0.000	0.996	0.004
G72.3 Periodic paralysis	0.003	0.996	0.000
G72.2 Myopathy due to other toxic agents	0.003	0.996	0.000
Y43 Primarily systemic agents	0.000	0.996	0.004
Y57.6 Other diagnostic agents	0.000	0.996	0.003
Y46.6 Other and unspecified antiepileptics	0.000	0.996	0.003
Y50.9 Central nervous system stimulant, unspecified	0.000	0.996	0.003
Y50.8 Other central nervous system stimulants	0.000	0.996	0.003
Y50.1 Opioid receptor antagonists	0.000	0.996	0.003
Y50.0 Analeptics	0.000	0.996	0.003
G72.4 Inflammatory myopathy, not elsewhere classified	0.003	0.996	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.996	0.003
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.996	0.003
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.997	0.003
D51.2 Transcobalamin II deficiency	0.000	0.997	0.003
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.000	0.997	0.003
D04.9 Skin, unspecified	0.003	0.997	0.000
E11.2 With renal complications	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.000	0.997	0.003
D04 Carcinoma in situ of skin	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.003
N89 Other noninflammatory disorders of vagina	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.997	0.003
K04.8 Radicular cyst	0.000	0.997	0.003
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
Y53.7 Emetics	0.000	0.997	0.003
Y53.5 Digestants	0.000	0.997	0.003
Y53.3 Saline and osmotic laxatives	0.000	0.997	0.003
Y53.0 Histamine H2-receptor antagonists	0.000	0.997	0.003
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
Y51.0 Anticholinesterase agents	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
Y53.6 Antidiarrhoeal drugs	0.000	0.997	0.003
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
A60.0 Herpesviral infection of genitalia and urogenital tract	0.000	0.997	0.003
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.997	0.003
M24.01 Loose body in joint (Shoulder region)	0.000	0.997	0.003
D04.4 Skin of scalp and neck	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
G70.0 Myasthenia gravis	0.003	0.997	0.000
Y43.4 Immunosuppressive agents	0.000	0.997	0.003
Y56.9 Topical agent, unspecified	0.000	0.997	0.003
Y56.8 Other topical agents	0.000	0.997	0.003
Y56.7 Dental drugs, topically applied	0.000	0.997	0.003
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
Y56.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
Y56.2 Local astringents and local detergents	0.000	0.997	0.003
Y56.1 Antipruritics	0.000	0.997	0.003
D51.8 Other vitamin B12 deficiency anaemias	0.000	0.997	0.003
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
G70.8 Other specified myoneural disorders	0.003	0.997	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.997	0.003
D62 Acute posthaemorrhagic anaemia	0.000	0.997	0.003
M24.0 Loose body in joint	0.000	0.997	0.003
D04.2 Skin of ear and external auricular canal	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.000	0.997	0.003
G70.2 Congenital and developmental myasthenia	0.003	0.997	0.000
G70.1 Toxic myoneural disorders	0.003	0.997	0.000
N89.3 Dysplasia of vagina, unspecified	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.000	0.997	0.003
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.997	0.003
D50-D53 Nutritional anaemias	0.000	0.997	0.003
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.997	0.003
S89.9 Unspecified injury of lower leg	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
R30 Pain associated with micturition	0.000	0.997	0.003
Y43.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
D60-D64 Aplastic and other anaemias	0.000	0.997	0.003
Y54.5 Other diuretics	0.000	0.997	0.003
G70.9 Myoneural disorder, unspecified	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.000	0.997	0.003
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.997	0.003
Y43.6 Enzymes, not elsewhere classified	0.000	0.997	0.003
Y43.5 Acidifying and alkalising agents	0.000	0.997	0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.003
M24.03 Loose body in joint (Forearm)	0.000	0.997	0.003
Y43.2 Antineoplastic natural products	0.000	0.997	0.003
Y56.3 Emollients, demulcents and protectants	0.000	0.997	0.003
D04.0 Skin of lip	0.003	0.997	0.000
H10.9 Conjunctivitis, unspecified	0.000	0.997	0.003
I08.8 Other multiple valve diseases	0.003	0.997	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.997	0.003
Q54.0 Hypospadias, balanic	0.000	0.997	0.003
Y43.1 Antineoplastic antimetabolites	0.000	0.997	0.003
Y49.9 Psychotropic drug, unspecified	0.000	0.997	0.003
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
Y49.7 Psychostimulants with abuse potential	0.000	0.997	0.003
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.997	0.003
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
M24.05 Loose body in joint (Pelvic region and thigh)	0.000	0.997	0.003
D04.8 Skin of other sites	0.003	0.997	0.000
N89.7 Haematocolpos	0.003	0.997	0.000
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.003	0.997	0.000
N89.4 Leukoplakia of vagina	0.003	0.997	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.997	0.003
Z49.1 Extracorporeal dialysis	0.003	0.997	0.000
C71.1 Frontal lobe	0.003	0.997	0.000
G73.7 Myopathy other diseases classified elsewhere	0.002	0.997	0.000
G73.6 Myopathy in metabolic diseases	0.002	0.997	0.000
G73.5 Myopathy in endocrine diseases	0.002	0.997	0.000
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G73.3 Myasthenic syndromes in other diseases classified elsewhere	0.002	0.997	0.000
G73.2 Other myasthenic syndromes in neoplastic disease	0.002	0.997	0.000
G73.1 Eaton-Lambert syndrome	0.002	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.002
D11.0 Parotid gland	0.000	0.997	0.003
S79.9 Unspecified injury of hip and thigh	0.000	0.997	0.003
T23.3 Burn of third degree of wrist and hand	0.000	0.997	0.003
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.997	0.003
D63.0 Anaemia in neoplastic disease	0.000	0.997	0.003
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.997	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.002
G73.0 Myasthenic syndromes in endocrine diseases	0.002	0.997	0.000
N89.1 Moderate vaginal dysplasia	0.002	0.997	0.000
M79.69 Pain in limb (Site unspecified)	0.000	0.997	0.003
I61.8 Other intracerebral haemorrhage	0.000	0.997	0.002
N89.0 Mild vaginal dysplasia	0.002	0.997	0.000
C71.9 Brain, unspecified	0.002	0.997	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.997	0.002
M24.09 Loose body in joint (Site unspecified)	0.000	0.998	0.002
M24.08 Loose body in joint (Other)	0.000	0.998	0.002
M24.00 Loose body in joint (Multiple sites)	0.000	0.998	0.002
D04.1 Skin of eyelid, including canthus	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.000	0.998	0.002
M24.06 Loose body in joint-Lower leg	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
R30.1 Vesical tenesmus	0.000	0.998	0.002
Y49.2 Other and unspecified antidepressants	0.000	0.998	0.002
C71.2 Temporal lobe	0.002	0.998	0.000
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.002	0.998	0.000
N89.6 Tight hymenal ring	0.002	0.998	0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.000	0.998	0.002
Q54 Hypospadias	0.000	0.998	0.002
D61.1 Drug-induced aplastic anaemia	0.000	0.998	0.002
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.998	0.002
M24.04 Loose body in joint (Hand)	0.000	0.998	0.002
S72.30 Fracture of shaft of femur (closed)	0.000	0.998	0.002
A87 Viral meningitis	0.002	0.998	0.000
Q54.1 Hypospadias, penile	0.000	0.998	0.002
Q54.8 Other hypospadias	0.000	0.998	0.002
T23.2 Burn of second degree of wrist and hand	0.000	0.998	0.002
D66 Hereditary factor VIII deficiency	0.000	0.998	0.002
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.998	0.002
D61 Other aplastic anaemias	0.000	0.998	0.002
F25.9 Schizoaffective disorder, unspecified	0.000	0.998	0.002
D53 Other nutritional anaemias	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.002	0.998	0.000
H95.1 Other disorders following mastoidectomy	0.000	0.998	0.002
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.998	0.002
N71.9 Inflammatory disease of uterus, unspecified	0.002	0.998	0.000
S82.00 Fracture of patella (closed)	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.002
M24.02 Loose body in joint (Upper arm)	0.000	0.998	0.002
T23 Burn and corrosion of wrist and hand	0.000	0.998	0.002
C71.7 Brain stem	0.002	0.998	0.000
J39.2 Other diseases of pharynx	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.002
Y44.7 Plasma substitutes	0.000	0.998	0.002
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.002
Z48.0 Attention to surgical dressings and sutures	0.002	0.998	0.000
F25.1 Schizoaffective disorder, depressive type	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.002
Z49.0 Preparatory care for dialysis	0.002	0.998	0.000
F22.0 Delusional disorder	0.000	0.998	0.002
Q54.4 Congenital chordee	0.000	0.998	0.002
Q54.3 Hypospadias, perineal	0.000	0.998	0.002
Q54.2 Hypospadias, penoscrotal	0.000	0.998	0.002
Z49 Care involving dialysis	0.002	0.998	0.000
D60.8 Other acquired pure red cell aplasias	0.000	0.998	0.002
D60.1 Transient acquired pure red cell aplasia	0.000	0.998	0.002
D60.0 Chronic acquired pure red cell aplasia	0.000	0.998	0.002
D63.1 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.002
H02.1 Ectropion of eyelid	0.002	0.998	0.000
F25 Schizoaffective disorders	0.000	0.998	0.002
D55-D59 Haemolytic anaemias	0.000	0.998	0.002
C71.6 Cerebellum	0.002	0.998	0.000
Q54.9 Hypospadias, unspecified	0.000	0.998	0.002
R77.9 Abnormality of plasma protein, unspecified	0.002	0.998	0.000
Z49.2 Other dialysis	0.002	0.998	0.000
A87.8 Other viral meningitis	0.002	0.998	0.000
A87.1 Adenoviral meningitis	0.002	0.998	0.000
A87.0 Enteroviral meningitis	0.002	0.998	0.000
D61.0 Constitutional aplastic anaemia	0.000	0.998	0.002
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.998	0.002
F25.2 Schizoaffective disorder, mixed type	0.000	0.998	0.002
M79.7 Fibromyalgia	0.000	0.998	0.002
D60.9 Acquired pure red cell aplasia, unspecified	0.000	0.998	0.002
R74 Abnormal serum enzyme levels	0.002	0.998	0.000
D61.8 Other specified aplastic anaemias	0.000	0.998	0.002
D61.3 Idiopathic aplastic anaemia	0.000	0.998	0.002
D61.2 Aplastic anaemia due to other external agents	0.000	0.998	0.002
D53.8 Other specified nutritional anaemias	0.000	0.998	0.002
D53.2 Scorbutic anaemia	0.000	0.998	0.002
D53.0 Protein deficiency anaemia	0.000	0.998	0.002
T84.2 Mechanical complication of internal fixation device of other bones	0.000	0.998	0.002
Y44.6 Natural blood and blood products	0.000	0.998	0.002
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
R17 Unspecified jaundice	0.002	0.998	0.000
R30.9 Painful micturition, unspecified	0.000	0.998	0.002
K11.2 Sialoadenitis	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.000	0.998	0.001
A60 Anogenital herpesviral [herpes simplex] infections	0.000	0.998	0.002
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.000	0.998	0.002
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
N89.5 Stricture and atresia of vagina	0.002	0.998	0.000
D52 Folate deficiency anaemia	0.000	0.998	0.002
A87.2 Lymphocytic choriomeningitis	0.001	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
D53.9 Nutritional anaemia, unspecified	0.000	0.998	0.002
K74.6 Other and unspecified cirrhosis of liver	0.000	0.998	0.002
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.002	0.998	0.000
T23.7 Corrosion of third degree of wrist and hand	0.000	0.998	0.002
T23.6 Corrosion of second degree of wrist and hand	0.000	0.998	0.002
T23.5 Corrosion of first degree of wrist and hand	0.000	0.998	0.002
T23.4 Corrosion of unspecified degree of wrist and hand	0.000	0.998	0.002
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.000	0.998	0.001
D67 Hereditary factor IX deficiency	0.000	0.998	0.002
C71.4 Occipital lobe	0.002	0.998	0.000
D56 Thalassaemia	0.000	0.998	0.001
A49.1 Streptococcal infection, unspecified	0.002	0.998	0.000
T23.1 Burn of first degree of wrist and hand	0.000	0.998	0.002
F25.8 Other schizoaffective disorders	0.000	0.998	0.001
D57 Sickle-cell disorders	0.000	0.998	0.001
D55 Anaemia due to enzyme disorders	0.000	0.998	0.001
F22 Persistent delusional disorders	0.000	0.998	0.002
M79.78 Fibromyalgia (Other)	0.000	0.998	0.001
M79.77 Fibromyalgia (Ankle and foot)	0.000	0.998	0.001
M79.76 Fibromyalgia (Lower leg)	0.000	0.998	0.001
M79.75 Fibromyalgia (Pelvic region and thigh)	0.000	0.998	0.001
M79.74 Fibromyalgia (Hand)	0.000	0.998	0.001
M79.73 Fibromyalgia (Forearm)	0.000	0.998	0.001
M79.72 Fibromyalgia (Upper arm)	0.000	0.998	0.001
M79.71 Fibromyalgia (Shoulder region)	0.000	0.998	0.001
D41.0 Kidney	0.000	0.998	0.002
Q60.2 Renal agenesis, unspecified	0.002	0.998	0.000
R41.3 Other amnesia	0.000	0.998	0.002
S72.10 Pertrochanteric fracture (closed)	0.000	0.998	0.002
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.998	0.002
H90.2 Conductive hearing loss, unspecified	0.002	0.998	0.000
D56.3 Thalassaemia trait	0.000	0.998	0.001
M75.0 Adhesive capsulitis of shoulder	0.000	0.998	0.002
S20.8 Superficial injuries of other and unspecified parts of thorax	0.002	0.998	0.000
O63.9 Long labour, unspecified	0.002	0.998	0.000
Q60.0 Renal agenesis, unilateral	0.002	0.998	0.000
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]	0.001	0.998	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.000	0.998	0.001
A60.9 Anogenital herpesviral infection, unspecified	0.000	0.998	0.001
A60.1 Herpesviral infection of perianal skin and rectum	0.000	0.998	0.001
I35.8 Other aortic valve disorders	0.000	0.998	0.002
S72.3 Fracture of shaft of femur	0.000	0.998	0.002
D52.8 Other folate deficiency anaemias	0.000	0.998	0.001
D52.1 Drug-induced folate deficiency anaemia	0.000	0.998	0.001
D52.0 Dietary folate deficiency anaemia	0.000	0.998	0.001
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.000	0.998	0.001
D04.6 Skin of upper limb, including shoulder	0.001	0.998	0.000
M79.70 Fibromyalgia (Multiple sites)	0.000	0.998	0.001
C77.2 Intra-abdominal lymph nodes	0.002	0.998	0.000
D56.9 Thalassaemia, unspecified	0.000	0.998	0.001
D56.8 Other thalassaemias	0.000	0.998	0.001
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.000	0.998	0.001
D56.2 Delta-beta thalassaemia	0.000	0.998	0.001
D56.0 Alpha thalassaemia	0.000	0.998	0.001
M79.2 Neuralgia and neuritis, unspecified	0.000	0.998	0.001
D64 Other anaemias	0.000	0.998	0.001
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.001	0.999	0.000
N39.9 Disorder of urinary system, unspecified	0.001	0.999	0.000
T63.4 Venom of other arthropods	0.000	0.999	0.001
S89 Other and unspecified injuries of lower leg	0.000	0.999	0.001
D55.9 Anaemia due to enzyme disorder, unspecified	0.000	0.999	0.001
D55.8 Other anaemias due to enzyme disorders	0.000	0.999	0.001
D55.3 Anaemia due to disorders of nucleotide metabolism	0.000	0.999	0.001
D55.2 Anaemia due to disorders of glycolytic enzymes	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations